Orexo AB (publ) (ORXOF) Financials

ORXOF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 53.0 million 25.1 million
March 31, 2026 63.8 million 25.7 million
Dec. 31, 2025 141.2 million 88.1 million
Sept. 30, 2025 54.7 million 78.3 million

ORXOF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.8 million 391345
March 31, 2026 -3.5 million 334283
Dec. 31, 2025 16.4 million ?
Sept. 30, 2025 -1.1 million ?

ORXOF Net Income

No data available :(

ORXOF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 28.5 million - 1.0 million
March 31, 2026 40.3 million - 731246
Dec. 31, 2025 98.8 million 52.4 million 912113
Sept. 30, 2025 11.1 million 49.8 million 2.0 million

ORXOF Shares Outstanding

No data available :(

ORXOF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 175075 5.5 million 6.0 million 216270
March 31, 2026 10446 5.2 million 3.9 million -10446
Dec. 31, 2025 - 4.7 million 3.2 million 423569
Sept. 30, 2025 - 6.5 million 6.4 million 4.2 million

ORXOF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 360450 10298
March 31, 2026 522318 52231
Dec. 31, 2025 357506 3.9 million
Sept. 30, 2025 12.5 million 1.9 million

ORXOF

Price: $1.77

52 week price:
1.77
3.23

Earnings Per Share: -1.27 USD

P/E Ratio: -2.54

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 73.8 million

Links: